XETRA - Delayed Quote EUR
CureVac N.V. (5CV.DE)
3.6000
+0.0400
+(1.12%)
At close: May 23 at 5:35:40 PM GMT+2
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
101,851
101,851
-267,887
-286,177
-733,128
Investing Cash Flow
-18,444
-18,444
-55,200
-93,499
-127,901
Financing Cash Flow
-5,114
-5,114
230,893
63,173
344,964
End Cash Position
481,748
481,748
402,452
495,797
811,464
Capital Expenditure
-18,444
-18,444
-55,200
-93,222
-127,901
Issuance of Capital Stock
0
0
235,840
66,484
404,062
Issuance of Debt
--
--
--
0
0
Repayment of Debt
-5,114
-5,114
-5,193
-4,221
-28,183
Repurchase of Capital Stock
--
--
--
--
-30,915
Free Cash Flow
83,407
83,407
-323,087
-379,399
-861,029
12/31/2021 - 8/25/2020
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
22UA.DE BioNTech SE
85.90
-1.26%
0QF.DE Moderna, Inc.
22.70
-2.34%
HPHA.DE Heidelberg Pharma AG
3.3100
-0.90%
AYJ.F Valneva SE
2.7780
-2.32%
0QF.F Moderna, Inc.
22.93
-1.76%
BIO3.DE Biotest Aktiengesellschaft
30.00
0.00%
7V0.DE Darwin AG
30.20
+2.03%
PRTCl.XC
88Q.DE 4basebio PLC
13.10
0.00%
4880.T CellSource Co., Ltd.
629.00
-1.10%